Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Perrigo Company plc (PIG.F)

Compare
22.20
0.00
(0.00%)
As of April 9 at 10:33:53 AM GMT+2. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Patrick Lockwood-Taylor President, CEO & Director 1.4M -- 1969
Mr. Eduardo Guarita Bezerra Executive VP & CFO 870.6k -- 1976
Mr. Ronald C. Janish Chief Transformation Officer and Executive VP of Global Operations & Supply Chain 1.32M -- 1966
Ms. Catherine C. B. Schmelter Executive VP & President of Consumer Self-Care Americas 777.09k -- 1970
Mr. Roberto Khoury Executive VP & President of Consumer Self-Care International 783.51k -- 1981

Perrigo Company plc

The Sharp Building
Hogan Place
Dublin, D02 TY74
Ireland
353 1 709 4000 https://www.perrigo.com
Sector: 
Healthcare
Full Time Employees: 
8,379

Description

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Corporate Governance

Perrigo Company plc’s ISS Governance QualityScore as of April 1, 2025 is 1. The pillar scores are Audit: 4; Board: 1; Shareholder Rights: 1; Compensation: 2.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 5, 2025 at 8:00 PM UTC - May 19, 2025 at 8:00 PM UTC

Perrigo Company plc Earnings Date

Recent Events

March 7, 2025 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers